Department of Clinical Radiology, Medical School, University of Ioannina, University Campus, 45110, Ioannina, Greece.
Department of Medical Physics, Medical School, University of Ioannina, University Campus, 45110, Ioannina, Greece.
Eur Radiol. 2020 Aug;30(8):4284-4294. doi: 10.1007/s00330-020-06767-z. Epub 2020 Mar 30.
To evaluate the biochemical milieu in testes with nonobstructive azoospermia (NOA) by using proton MR spectroscopy (1H-MRS) in detecting differences in testicular metabolites between histological stages of NOA and in assessing the possible presence of spermatozoa before microdissection testicular sperm extraction (mTESE).
Forty-nine NOA men and fifty age-matched controls were included in this prospective study. A single-voxel point-resolved spectroscopy sequence with TR/TE (2000/25 ms) was used. NOA testes were classified using the higher Johnsen score (hJS) (group 1, hJS ≥ 8; and group 2, hJS < 8). Nonparametric statistical tests were used to assess differences in normalized metabolite concentrations, defined as ratios of the metabolite concentrations versus creatine concentration between (a) NOA and controls, (b) NOA groups, and (c) NOA with positive and negative sperm retrieval.
Normalized concentrations of total choline (median 0.396 vs 1.09 mmol/kg, p = 0.002), myo-inositol (median 1.985 vs 3.19 mmol/kg, p = 0.002), and total lipids and macromolecules (TLM) resonating at 0.9 ppm (median 0.962 vs 2.43 mmol/kg, p = 0.024), 1.3 ppm (median 4.88 vs 10.7 mmol/kg, p = 0.043), and 2.0 ppm (median 2.33 vs 5.96 mmol/kg, p = 0.007) were reduced in NOA testes compared with controls. Decreased concentrations of TLM 2.0 (median 3.755 vs 0.436 mmol/kg, p = 0.043) were found in group 2 compared with group 1. Increased normalized concentrations of glutamate were observed in NOA testes with failed sperm retrieval (median 0.321 vs 0.000 mmol/kg, p = 0.028).
1H-MRS provides metabolic information about the testis in NOA patients and assesses spermatogenic status before mTESE.
• NOA testes differed from age-matched controls, in terms of reduced normalized concentrations of tChol, mI, and lipids. • TLM 2.0 peaks were found useful in the identification of NOA testes with the presence of foci of advanced spermatogenesis up to the haploid gamete stage. • Glu proved a reliable metabolic signature of spermatogenesis in NOA population by assessing the possible presence of sperm after mTESE.
通过质子磁共振波谱(1H-MRS)检测非梗阻性无精子症(NOA)睾丸组织代谢物在组织学分期之间的差异,评估生化微环境,并评估在进行微量睾丸精子提取(mTESE)之前可能存在精子的情况。
本前瞻性研究纳入 49 名 NOA 男性和 50 名年龄匹配的对照者。采用 TR/TE(2000/25ms)的单体素点分辨波谱序列。根据更高的约翰森评分(hJS)对 NOA 睾丸进行分类(hJS≥8 为组 1,hJS<8 为组 2)。采用非参数统计检验评估以下各项之间标准化代谢物浓度的差异:(a)NOA 与对照组之间;(b)NOA 组之间;(c)NOA 中精子提取阳性与阴性之间。
与对照组相比,NOA 睾丸中总胆碱(中位数 0.396 对 1.09mmol/kg,p=0.002)、肌醇(中位数 1.985 对 3.19mmol/kg,p=0.002)以及共振在 0.9ppm(中位数 0.962 对 2.43mmol/kg,p=0.024)、1.3ppm(中位数 4.88 对 10.7mmol/kg,p=0.043)和 2.0ppm(中位数 2.33 对 5.96mmol/kg,p=0.007)处的总脂质和大分子(TLM)浓度降低。与组 1 相比,组 2 的 TLM 2.0(中位数 3.755 对 0.436mmol/kg,p=0.043)浓度降低。在 mTESE 失败的 NOA 睾丸中,谷氨酸的标准化浓度增加(中位数 0.321 对 0.000mmol/kg,p=0.028)。
1H-MRS 可提供关于 NOA 患者睾丸的代谢信息,并可在 mTESE 前评估生精状态。
•NOA 睾丸与年龄匹配的对照组相比,其总胆碱、肌醇和脂质的标准化浓度降低。•TLM 2.0 峰有助于识别具有至单倍体配子阶段的高级生精灶的 NOA 睾丸。•Glu 通过评估 mTESE 后可能存在精子的情况,成为评估 NOA 人群生精情况的可靠代谢标志物。